Moderna asks FDA to authorize first COVID-19 vaccine for very young children
The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Read more on NPR
Science - April 28, 2022 at 06:00PM - Moderna asks FDA to authorize first COVID-19 vaccine for very young children
Không có nhận xét nào:
Đăng nhận xét